Valproic Acid Upregulates NKG2D Ligand Expression through an ERK-dependent Mechanism and Potentially Enhances NK Cell-mediated Lysis of Myeloma

Por Wu, Xiaosong, Tao, Yi, Hou, Jun, Meng, Xiuqin, Shi, Jumei
Publicado em 2012

Synergistic Activity of Carfilzomib and Panobinostat in Multiple Myeloma Cells via Modulation of ROS Generation and ERK1/2

Por Gao, Lu, Gao, Minjie, Yang, Guang, Tao, Yi, Kong, Yuanyuan, Yang, Ruixue, Meng, Xiuqin, Ai, Gongwen, Wei, Rong, Wu, Huiqun, Wu, Xiaosong, Shi, Jumei
Publicado no Biomed Res Int (2015)

Arsenic trioxide-mediated growth inhibition of myeloma cells is associated with an extrinsic or intrinsic signaling pathway through activation of TRAIL or TRAIL receptor 2

Por Wu, Xiaosong, Shi, Jumei, Wu, Yi, Tao, Yi, Hou, Jun, Meng, Xiuqin, Hu, Xiaojing, Han, Ying, Jiang, Wei, Tang, Siyuan, Zangari, Maurizio, Tricot, Guido, Zhan, Fenghuang
Publicado em 2010

Carfilzomib enhances natural killer cell-mediated lysis of myeloma linked with decreasing expression of HLA class I

Por Yang, Guang, Gao, Minjie, Zhang, Yiwen, Kong, Yuanyuan, Gao, Lu, Tao, Yi, Han, Ying, Wu, Huiqun, Meng, Xiuqin, Xu, Hongwei, Zhan, Fenghuang, Wu, Xiaosong, Shi, Jumei
Publicado no Oncotarget (2015)